Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors

J Gastroenterol Hepatol. 2012 Aug;27(8):1341-7. doi: 10.1111/j.1440-1746.2012.07165.x.

Abstract

Background and aims: We evaluated efficacy of exercise and diet modification for steatosis improvement of non-obese non-alcoholic fatty liver disease (NAFLD) patients.

Methods: We analyzed retrospectively the clinical and histological parameters of consecutive living liver donors, who experienced repeated liver biopsies due to steatosis and were treated using exercise and diet modification.

Results: From 1995 to 2009, among a total of 1365 potential living liver donors with NAFLD seen on the initial liver biopsy, 120 consecutive donors with steatosis ≥ 30% or an estimated donor-recipient weight ratio < 0.8, underwent exercise and diet modification and received follow-up liver biopsy at our institution. Median age was 33 years, and median interval between the two consecutive biopsies was 10 weeks (range, 1-39). At the time of initial biopsy, the number of normal body mass index, overweight, and obese donors was 49 (40.8%), 65 (54.2%), and 6 (5.0%), respectively. After lifestyle modification, weight reduction and steatosis improvement were observed in 92 (76.7%) and 103 (85.8%) donors, respectively, at the time of follow-up biopsy. On multivariate analysis, initially higher steatosis (hazard ratio [HR] 1.03, P = 0.02), total cholesterol reduction ≥ 10% (HR 5.59, P = 0.02), and weight reduction ≥ 5% (HR 6.63, P = 0.03) were significantly associated with ≥ 20% steatosis improvement in 120 donors with NAFLD, after exercise and diet modification.

Conclusions: Exercise and diet modification were effective in reducing steatosis in potential living liver donors with non-obese NAFLD. Total cholesterol reduction ≥ 10% could be used as a non-invasive predictor for steatosis improvement in liver donors with NAFLD, after exercise and diet modification.

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / blood
  • Biopsy
  • Body Mass Index
  • Chi-Square Distribution
  • Cholesterol / blood
  • Diet, Reducing*
  • Exercise*
  • Fatty Liver / blood
  • Fatty Liver / diagnosis
  • Fatty Liver / physiopathology
  • Fatty Liver / therapy*
  • Female
  • Humans
  • Liver Transplantation*
  • Living Donors*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Non-alcoholic Fatty Liver Disease
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Reduction Behavior*
  • Time Factors
  • Treatment Outcome
  • Weight Loss
  • Young Adult

Substances

  • Biomarkers
  • Cholesterol